The present invention relates to compounds IIf and methods useful for inhibiting one or more interleukin-1 receptor-associated kinases ("IRAK"). In some embodiments, a provided compound inhibits IRAK-1 and IRAK-4. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and compositions comprising them for use in the treatment of various disorders.